Preimplantation genetic screening abbreviated as PGS refers to removing one or more cells from an in-vitro fertilization embryo to test for chromosomal normalcy. PGS screens the embryo for normal chromosome number. All of us humans have 23 pairs of chromosomes, totaling 46. Having an extra or a missing chromosome causes problems. An example of problems caused by chromosomal anomaly is Down Syndrome wherein the baby has an extra chromosome number 21. A PGS screening helps detect Down Syndrome and more such problems.
Several studies have shown that overall, about 50 per cent of human preimplantation embryos from IVF are chromosomally abnormal. The rate of abnormalities is affected greatly by female age. Chromosomes in eggs from older women have a significantly increased rate of abnormalities. To a great extent, chromosomal abnormalities are responsible for failure of implantation of IVF embryos. Chromosomal abnormalities are also responsible for about 70 percent of miscarriages in early pregnancy.
PGS is recommended when the doctor identifies you at increased risk for having embryos with abnormal chromosomes are best candidates for PGS. This may be the case when:
Specifically, PGS can identify chromosomal abnormalities such as: